Sodium pyruvate
CAS No. 113-24-6
Sodium pyruvate( —— )
Catalog No. M20910 CAS No. 113-24-6
Sodium pyruvate is a antioxidant potentially used to treatment of chronic obstructive pulmonary disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium pyruvate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium pyruvate is a antioxidant potentially used to treatment of chronic obstructive pulmonary disease.
-
DescriptionSodium pyruvate is a antioxidant potentially used to treatment of chronic obstructive pulmonary disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaMetabolic Disease
-
IndicationChronic Obstructive Pulmonary Disease (COPD)
Chemical Information
-
CAS Number113-24-6
-
Formula Weight110.04
-
Molecular FormulaC3H3NaO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (908.76 mM)
-
SMILESCC(=O)C(=O)[O-].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.L S Li et al. [Treatment effect of sodium pyruvate nasal spray on allergic rhinitis].[J]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery 2017.
molnova catalog
related products
-
TIC10
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.
-
Ganoderic acid M
Ganoderic acid Me and/or ganoderic acid T have obvious action for inhibiting human tumor cell growth or proliferation, at the same time its toxicity for normal cells is low.
-
Ganolucidic acid D
Ganolucidic acid D, also known as ganolucidate D, is a triterpenoid.
Cart
sales@molnova.com